SCHEMBL3025404

SCHEMBL3025404

COc1ccc(N)c(Nc2ccc3c(c2)CCCC3CN(C(=O)O)C(C)(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 20/20 0.40
KDM6B O15054 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027641 0.87 KDM4C (0.39) KDM4CKDM6B
SCHEMBL3027646 0.87 KDM4C (0.39) KDM4CKDM6B
SCHEMBL3020437 0.78 HTR6 (0.43) KDM4C
SCHEMBL3667381 0.77 KDM4C (0.35) KDM4C
SCHEMBL3664922 0.77 BACE1 (0.37)
SCHEMBL3026909 0.76 PIK3CA (0.32)
SCHEMBL3664919 0.76 BACE1 (0.36) KDM4C
SCHEMBL3667380 0.76 MAPK8 (0.33) KDM4C
SCHEMBL3726142 0.72 KDM4C (0.38) KDM4CKDM6B
SCHEMBL3666540 0.70 TXNRD1 (0.35) KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197679-A1 COMPOUNDS GLAXO GROUP LIMITED 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197679-A1 COMPOUNDS NRDC, MRPL21, NISCH KDM4C 3322/4885KDM6B 4243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.